Infections in lung transplant recipients

Clinics in Chest Medicine

Volumn 18, Issue 2, 1997, Pages 339-351

  Chaparro, C ^a   Kesten, S ^a  

^a RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; ANTIBIOTIC AGENT; AZATHIOPRINE; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN A; CYTOMEGALOVIRUS ANTIBODY; FLUCONAZOLE; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; NYSTATIN; PENICILLIN G; TACROLIMUS;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTION; BRONCHIOLITIS; CLINICAL PROTOCOL; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFECTION RISK; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG LAVAGE; LUNG TRANSPLANTATION; MYCOSIS; ORAL DRUG ADMINISTRATION; ORGAN DONOR; PNEUMOCYSTIS PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECIPIENT; REVIEW; SURGICAL TECHNIQUE; TRANSBRONCHIAL BIOPSY;

EID: 0030913624     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70383-X     Document Type: Article

References (68)

1. R. Aeba J. Stout N. Francalancia Aspects of lung transplantation that contribute to increased severity of pneumonia J Thorac Cardiovasc Surg 106 1993 449 457
2. Statement ATS Guidelines for the initial management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy Am Rev Respir Dis 148 1993 1418 1426
3. K.O. Bando I.L. Paradis K. Komatsu Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation J Thorac Cardiovasc Surg 109 1995 49 59
4. K. Bando I.L. Paradis H. Konishi Obliterative bronchiolitis after lung and heart–lung transplantation: An analysis of risk factors and management J Thorac Cardiovasc Surg 110 1995 4 14
5. A.G. Bassiri R.E. Girgis S. Theodore Actinomyces odontolyticus thoracopulmonary infections. Two cases in lung and heart–lung transplant recipients and review of the literature Am J Respir Crit Care Med 152 1995 374 376
6. R.G. Brooks J.M. Hoffla S.W. Jamieson Infectious complications in heart–lung transplant recipients Am J Med 79 1985 412 422
7. J.M. Calhom L. Nichols R. Davis Single lung transplant: Factors in postoperative CMV infection J Thorac Cardiovasc Surg 103 1992 21 26
8. K. Carbone L. Pennington L. Gimenez Mucormycosis in renal transplant patients—a report of two cases and review of the literature Q J Med New Series 57 1985 825 831
9. J. Cerrina F. Le Roy F. Parquin Infectious complications after heart–lung and lung transplantation G.A. Patterson L. Courand Lung Transplantation 1995 Elsevier Science BV Amsterdam 517 539
10. C. Chaparro D. Chamberlain J. Maurer Acute lung injury in lung allografts J Heart Lung Transplant 14 1995 267 273
11. C. Chaparro J.R. Maurer D. Chamberlain Causes of death in lung transplant recipients J Heart Lung Transplant 13 1994 758 766
12. C. Chaparro J. Maurer D. Chamberlain Role of open lung biopsy for diagnosis in lung transplant recipients: Ten-year experience Ann Thorac Surg 59 1995 928 932
13. C. Chaparro M. Scavuzzo S. Kesten Infectious complications in lung transplant recipients with bronchiolitis obliterans syndrome (BOS) Chest 108 1995 205 S
14. C. Chaparro M. Scavuzzo S. Kesten Mycobacterial infections in lung transplant recipients Chest 110 1996 221S
15. J.H. Dauber I.L. Paradis J.S. Dummer Infectious complications in pulmonary allograft recipients Clin Chest Med 11 1990 291 308
16. C.M. Dennie N. Briffa F. Wells The airway anastomosis: Is there a problem? Am Rev Respir Dis 147 1993 A197
17. M. Dolonish C. Rossm C. Chambers Mucociliary function in patients following single or lung–heart transplantation Am Rev Respir Dis 135 1987 A363
18. J. Dubois T. Bartter J. Gryn The physiologic effects of inhaled amphotericin B Chest 108 1995 750 753
19. J.S. Dummer C.G. Montero B.P. Griffith Infections in heart–lung transplant recipients Transplantation 41 1986 725 729
20. S. Duncan W. Grgurich A. Iacono A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation Am J Respir Crit Care Med 150 1994 146 152
21. S.R. Duncan I.L. Paradis S.A. Yousem Sequelae of cytomegalovirus pulmonary infections in lung allograft recipients Am Rev Respir Dis 146 1992 1419 1425
22. T.M. Egan F.C. Detterbeck M. Mill Improved results of lung transplantation for patients with cystic fibrosis J Thorac Cardiovasc Surg 109 1995 224 235
23. N.A. Ettinger T.L. Bailey E.P. Trulock Cytomegalovirus infection and pneumonitis impact after isolated lung transplantation Am Rev Respir Dis 147 1993 1017 1023
24. P. Flume T. Egan L. Paradowski Infectious complications of lung transplantation. Impact of cystic fibrosis Am J Respir Crit Care Med 149 1994 1601 1607
25. A.E. Frost C.K. Keller G.P. Noon Outcome of the native lung following single lung transplantation Am Rev Respir Dis 147 1993 A599
26. P.H. Gilligan Microbiology of airway disease in patients with cystic fibrosis Clin Microbiol Rev 4 1991 35 45
27. F.K. Gould R. Freeman C.E. Taylor Prophylaxis and management of cytomegalovirus pneumonitis after lung transplantation: A review of experience in one center J Heart Lung Transplant 12 1993 695 699
28. B.P. Griffith R.L. Hardesty A. Trento Heart–lung transplantation: Lessons learned and future hopes Ann Thorac Surg 43 1987 6 16
29. S. Gryzan I.L. Paradis A. Zeevi Unexpectedly high incidence of Pneumocystis carinii infection after lung–heart transplantation: Implication for lung defense and allograft survival Am Rev Respir Dis 137 1988 1269 1274
30. T. Higenbottan S. Stewart A. Penketh Transbronchial lung biopsy for the diagnosis of rejection in heart–lung transplant patients Transplantation 465 1988 532 539
31. J. Hosenpud R. Novick L. Bennett The registry on the international society for heart and lung transplantation: Thirteenth official report—1996 J Heart Lung Transplant 15 1996 655 674
32. J. Jereb D. Burwen S. Dooley Nosocomial outbreak of tuberculosis in a renal transplant unit: Application of a new technique for restriction fragment length polymorphism analysis of mycobacterium tuberculosis isolates J Infect Dis 168 1993 1219 1224
33. J.L. Keens C.R. Fuhrman S.A. Yousem Bronchiolitis obliterans in heart–lung transplantation patients AJR 153 1989 253 256
34. M.R. Kramer Bronchiolitis obliterans following heart–lung and lung transplantation Respir Med 88 1994 9 15
35. M.R. Kramer S.E. Marshal V.A. Starnes Infectious complications in heart–lung transplantation. Analysis of 200 episodes Arch Intern Med 153 1993 2010 2016
36. M.R. Kramer C. Stocher N.J. Lewiston Trimethoprim-sulfa-methoxasole prophylaxis for Pneumocystis carinii infections in heart–lung and lung transplantation—how effective and for how long? Transplantation 53 1992 586 589
37. J.M. Kriett C.M. Smith A.M. Hayden Lung transplantation without the use of antilymphocytic preparations J Heart Lung Transplant 13 1994 915 923
38. I.L. Kron C.G. Tribble J.A. Kern Successful transplantation of marginally acceptable thoracic organs Ann Surg 217 1993 518 524
39. F.L. Ladurie J. Cerrina F. Parquin Description and treatment of an outbreak of Aspergillus bronchitis in lung transplant recipients Am Rev Respir Dis 147 1993 A600
40. S.M. Levine J.I. Peters A. Anzueto Aspergillus infection in single lung transplant recipients Am Rev Respir Dis 147 1993 A599
41. N. Lewiston V. King D. Umetsu Cystic fibrosis patients who have undergone heart–lung transplantation benefit from maxillary sinus antrostomy and repeated sinus lavage Transplant Proc 23 1991 1207 1208
42. D.E. Low L.R. Kaiser D.A. Haydock The donor lung: Infectious and pathologic factors affecting outcome in lung transplantation J Thorac Cardiovasc Surg 106 1993 614 621
43. M.C. Mancini W.N. Tauxe Assessment of pulmonary clearance in heart–lung transplant recipients using technetium 99-m minimicronized albumin colloid Am Rev Respir Dis 133 1986 A11
44. J.R. Maurer D.E. Tullis R.F. Gossman Infectious complications following isolated lung transplantation Chest 101 1992 1056 1059
45. R. Miller L. Lanza J. Kline Mycobacterium tuberculosis in lung transplant recipients 152 1995 374 376
46. G. Morduchowicz D. Shmueli Z. Shapira Rhinocerebral mucormycosis in renal transplant recipients: Report of three cases and review of the literature Rev Infect Dis 8 1986 441 446
47. W.F. Morris S.J. Herman G.L. Weisbrod Bronchiolitis obliterans in heart–lung transplantation patients: Radiologic findings in 11 patients Radiology 179 1991 487 490
48. D.P. O'Hair C.P. Johnson A.M. Roza Treatment of transplant rejection in the presence of cytomegalovirus viremia Transplant Proc 22 1990 1815 1817
49. L.L. Orkin P.J. Byard P.B. Davis Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients J Clin Epidemiol 43 1990 125 131
50. I.L. Paradis W.F. Grgurich J.S. Drummer Rapid detection of cytomegalovirus pneumonia by evaluation of bronchoalveolar cells Am Rev Respir Dis 138 1988 697 702
51. I.L. Paradis S. Yousem B. Griffith Airway obstruction and bronchiolitis obliterans after lung transplantation Clin Chest Med 14 1993 751 763
52. G.A. Patterson J.D. Cooper Status of lung transplantation Surg Clin North Am 68 1988 545 548
53. G.A. Patterson J.D. Cooper B. Goldman Technique of successful clinical double lung transplantation Ann Thorac Surg 45 1988 626 633
54. C.V. Pava Fungal infections in solid-organ transplantation Clin Infect Dis 16 1993 677 688
55. A. Pomerance B. Madden M.M. Burke Transbronchial biopsy in heart and lung transplantation: Clinicopathologic correlations J Heart Lung Transplant 14 1995 761 763
56. W. Quinibi B. Al-Sibai S. Taher Mycobacterial infection after renal transplantation. Report of 14 cases and review of the literature Q J Med New Series 77 1990 1039 1060
57. J.P. Scott G. Fradet R.L. Smith Prospective study of transbronchial biopsies in the management of heart–lung and single-lung transplant patients J Heart Lung Transplant 10 1991 626 637
58. G.I. Snell A. deHoyos M. Krajden Pseudomonas cepacia in lung transplant recipients with cystic fibrosis Chest 103 1993 466 471
59. M. Soghikian V. Valentine G. Berry Impact of the ganciclovir prophylaxis on heart–lung and lung transplant recipients J Heart Lung Transplant 15 1996 881 887
60. S. Sunderasan J. Semenkovich L. Ochoa Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs J Thorac Cardiovasc Surg 109 1995 1075 1080
61. O.C. Tablan W.J. Martone C.F. Doershuk Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis: Risk factors and outcomes Chest 91 1987 527 532
62. T.H. The M. Van der Ploeg A. Van der Berg Direct detection of cytomegalovirus in peripheral blood leukocytes—a review of the antigenemia assay and polymerase chain reaction Transplantation 54 1992 193 198
63. C. Tomee G. Mannes T. van der Werf Serodiagnosis and monitoring of Aspergillus infections after lung transplantation Ann Intern Med 125 1996 197 201
64. Toronto Lung Transplant Group Unilateral lung transplantation for pulmonary fibrosis N Engl J Med 314 1986 1140 1145
65. C. Wendt J. Fox M. Hertz Paramyxovirus infection in lung transplant recipients J Heart Lung Transplant 14 1995 479 485
66. G. Westney S. Kesten A. DeHoyos Aspergillus infection in single and double lung transplant recipients Transplantation 61 1996 915 919
67. D.O. Wilson R.M. Rogers R.M. Hoffman Nutrition and chronic lung disease Am Rev Respir Dis 132 1985 1347 1365
68. M. Zenati R.D. Dowling J.S. Dummer Influence of the donor lung on development of early infections in lung transplant recipients J Heart Transplant 9 1990 502 508